Quantcast
Channel: News-Medical.Net onsolis News Feed
Viewing all articles
Browse latest Browse all 26

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

$
0
0
BioDelivery Sciences International, Inc. announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy.

Viewing all articles
Browse latest Browse all 26